GENEVA (Reuters) - The World Health Organization (WHO) said on Friday it is preparing guidelines on use of the drug remdesivir for COVID-19 and should be able to release them�in three to four weeks. Read full story ...
Related News
US gives full approval for antiviral remdesivir drug
Washington, Oct 23 : US regulators have given full approval for the antiviral drug remdesivir to treat the Covid-19 patients in hospitals. The US Food and Drug...
The Siasat Daily 2020-10-23WHO's Tedros says countries on "dangerous track" in pandemic
GENEVA (Reuters) - The world is now at a critical juncture in the COVID-19 pandemic and some...
The Star 2020-10-23Gilead shares rise after United States approves remdesivir as COVID-19 drug
Sign up for our COVID-19 newsletter to stay up-to-date on the latest coronavirus news throughout New York City (Reuters) – Shares of Gilead Sciences Inc
What to Know About Remdesivir, the First Drug Approved by the FDA to Treat COVID-19
President Donald Trump has spilled a lot of Twitter ink about potential treatments for COVID-19. Some of his suggestions have been dangerous or unproven. Others — in...
The Centralia Chronicle
2020-10-23
Remdesivir gets FDA approval for hospitalized COVID-19 patients
The Food and Drug Administration on Thursday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first...
Union Leader
2020-10-23
Gilead's remdesivir just got the first FDA approval to be used as a treatment for ...
A vial of remdesivir. ULRICH PERREY/POOL/AFP via Getty Images Gilead Sciences just received approval from the US Food and Drug Administration for its antiviral remdesivir...
Business Insider 2020-10-22Doctors question FDA approval of Gilead’s COVID-19 treatment and say it has limited benefits
Getty Images The Food and Drug Administration’s decision to grant a full approval to Gilead Sciences Inc.’s remdesivir is raising questions about the broader value of a...
Market Watch 2020-10-23